BNTX - BioNTech SE
102.16
0.660 0.646%
Share volume: 1,030,621
Last Updated: 03-09-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$101.50
0.66
0.01%
View ratios
| Fiscal Date | 03-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 05-06-2024 | |
| Cash flow financing | -8.424 M | |
| Other financing cash flows | 0.000 | |
| Cash flow | -342.687 M | |
| Net income | -340.311 M | |
| Depreciation | 41.364 M | |
| Changes in inventories | 373.036 M | |
| Changes in receivables | 1.771 B | |
| Investing Cashflow | -2.489 B | |
| Net Borrowings | -17.337 B | |
| Investing Activity Other | 0.000 | |
| Dividends Paid | 0.000 | |
| Exchange Rate Effect | 0.000 | |
| Capital Expenditures | -147.853 M | |
| Cash Change | 9.695 B |